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Some studies have reported in vitro inactivation of 
membrane enveloped viruses by Butylated hydroxy toluene (BHT). 
This study investigates the effect of orally administered 
BHT on primary infections of Herpes simplex virus (HSV) 
using rabbit corneas as the assay system . 
Assigned levels of BHT were incorporated into the diet 
of New Zealand White rabbits infected with HSV-l McKrae 
strain on the corneal surface of the eyes. The degree of 
infection was measured by a subjective assay. Rabbits 
rece iving BHT in their diet conSistently experienced lower 
levels of infection. The interpretation of this data is that 
orally administered BHT can be an effective inhibitor of 
primary infections by HSV in rabbits. 
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INTRODUCTION AND LITERATURE REVIEW 
Snipes, et al.. (1975) reported that the common food 
additi ve butylated hydroxy toluene (BHT) could inactivate 
lipid containing vi ruses including He r pes simpl ex virus 
(HSV) in vitro. Results of studie s by this same group, 
Keith, e t al., (1982) showed BHT to be an effective 
inhibitor of herpes cutaneous infections in mice when 
applied topically. Brugh (1977) demonstrated that dietary 
BHT , widely used as an additive to poultry feed, was an 
effective treatment for the protection of chickens exposed 
to either virulent or avirulent strains of Newcastle disease 
virus, also a membrane bound virus. Kim, et al., (1978) 
noted that BHT could inactivate cytomegalovirus and Semliki 
Forest virus, both membrane bound viruses. 
BHT is an antioxidant added to food that acts as a fat 
stablizer , preventing spoilage caused by oxidation. The 
Food and Drug Administration (FDA) has approved the addition 
of BHT to the human diet at a concentration of 0.02 percent 
(200 ppm) by weight based on the fat or oil content of the 
food (Handbook of Food Additives, 1972). For people living 
in the United Kingdom the level is 1 mg per day (Snipes, 
et al., 1975). 
Seventy-five percent of the daily intake of BHT is 
excreted in the urine and feces during the first 24 hours 
after ingestion in man with the remainder partitioning into 
the body ' s adipose tissue where it accumulates to an aver-
age of 1. 30 ppm and 0.2 3 ppm in the Uni ted States and the 
United Kingdom, respectively (Collings and Sharrat , 1970). 
In vitro studies have s hown t hat the BHT concentration 
necessary for antiviral activity of HSV corresponds to 
approximately ten t imes this level of accumulation in human 
adipose tissue (SnipL3, et al., 1975). 
There is disagreement regarding the biological effects 
that hi gh l evels of BHT can have on cells, organs and 
organisms. Studies involv ing long-term administration of 
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BHT to mice showed hyperplasia of hepatic bile ducts (Clapp, 
et al., 1973). Early studies reported terat ogenic abnor-
malities in rats (Brown, et al., 1959); subsequent experiments 
showed no teratogenic lesions resulted from BRT administration 
(Frawley, et al., 1965) . Thus it was reported that BHT was 
not a teratogenic agent (Johnson, 1965). Mice offspring 
whose mothers had received a diet of 0 . 5\ BHT during 
gestation demonstrated a fifty percent decrease in brain 
cholinesterase activity (Stokes, et al., 1972). DeRios , 
et al., (1978) reported that BHT protects against ultra-
violet (UV)-induced skin erythema and was found to be 
effective in reducing UV-induced carcinogenesis (Chan and 
Black, 1977). Gilbert and Golberg (1965) noted that BHT 
can e licie hyperfunctional liver enlargement but without 
histopathological evidence of hepatic damage. Numerous 
studies have found BHT to be noncarCinogenic, nonmutagenic, 
and generally nontoxic (Keith, et al., 1982). Probably of 
most importance was t he long- term study by Allen (1976) 
i ,n which dosages of BHT 20 0 t.imes g r e ater than is permis-
sible in the human diet demonstrated no il l e ffects on 
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the he alth of adult fema le primates . Also, no effect was 
noted on e mbryonic and feta l development r esulting from 
long-term exposure of BHT to the mothers both p rior to 
conception and during gestation . It has been suggested that 
the different effects e licited in primates and rodents may 
be a r e sult of differences in metaboli sm of BHT by these 
organisms (Daniel, et al., 1968). 
For a substance to be used as an antiviral compound it 
must be effective and safe for those to whom it is 
administered. Dietary leve ls of BHT of 0.5% by weight are 
considered to be reasonably safe (Takahashi and Hiroga, 1978). 
BHT appears to be an effective antiviral compound against 
memrane-bound viruses. The list of membrane bound viruse s 
is too large to enumerate here but includes varicella-zoster 
virus (chickenpox and shingles), Epstein-Barr virus (infec-
tious mononucleosis and Burkitt's African lymyphoma), 
ctyomegalovirus (ctyomegalic inclusion disease), and Herpes 
simplex virus (herpes keratitis, herpes labialis, and herpes 
p rogenitalis) . 
Herpes keratitis is a HSV infection of the cornea l 
and conjunctival epithelium of mammalian eyes. There are 
an es timated 300,000 cases of this disease per year in the 
Un i ted States (Vision Research, US Department of Health, 
Education, and Welfare, 1977), and it is the major cause of 
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blindness due t o cornea l infections (Gan garosa, et a 1. , 
1979 ) . Primary infections can occur via direct contact of 
HSV with the superficial tissues of the e ye or b y n e urogenic 
movement of HSV into the ophthalmic branch of the trigeminal 
n e rve from the trigeminal gan g lia (Kristensson, et a1., 
1971) . Following subsidence of the primary infection, the 
virus can reside in a quiescent (la ~ent) state until which 
time recurrent infections may be elicited. The site of this 
latent state has bee n demonstrated to be the trigeminal 
ganglia (Kwan, et a1. , 1981), but low levels of HSV have also 
been found at the site of recurrence even when no corneal 
lesions were present (Neshurn, et a1., 1972). It has been 
proposed that viral shedding in lacrimal and salivary glands 
may be responsible for recurrent herpes infection (Kaufman, 
et al., 1967). Frequent recurrence of HSV infection can 
cause irreversible damage to the corneal epithelium and 
possibly cause deep stroma keratitis (Vision Research, US 
Department of Health, Education and Welfare, 1977). 
The purpose of this research was to investigate the 
effect of orally administered BHT on rabbit corneas infected 
with Herpes simplex virus. The facility of observation of 
lesions on the surface of the eye and the ability to induce 
recurrent infections artificially make the rabbit eye an 
effective model for studying the effects of this antiviral 
agent on HSV infections. This study includes investigations 
of the effectiveness of BHT at different dosages, the timing 
of administration for the most effective response and BHT's 
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effectiveness on different levels of vira l exposure. 
MATERIALS AND METHODS 
Rabbits 
New Zealand White rabbits (Coccus doities) we re used 
for all experiments. Three week old animals we i ghing 
approximately 0 .5-0 .75 kilograms were caged and allowed to 
acclimate in the laboratory for a ~riod of four days. The 
rabbits were fed chow (Purina) and allowed to drink water 
ad libitum. The average daily food intake of each rabbit 
was measured by weight over a three day period and recorded. 
Treatment 
A concentrated treatment solution of BHT was obtained 
by dissolving a known quantity of BRT (Sigma Chemical Co.) 
in 100\ ethanol (ETOH) by weight/volume. The solution was 
applied to one half the average daily food intake, by weight, 
of the rabbits to be treated such that the food would be 
coated with sufficient BHT to make up a known (assigned) per-
centage of the animals' daily food intake. The food was 
heated in an oven at 60·C to allow evaporation of the ETOH 
from the treated chow, leaving the BRT on the food. The 
treated chow was then added to the rabbits' diet at the top 
of the food bin in an effort to ensure its consumption first . 
(Since this one half daily food intake was treated with the 
entire daily dosage of BHT, a rabbit consuming its average 
daily food intake consumed its daily dOBe of BHT.) After 
initiation, the BRT treatment continued for the entire course 
of the experiment. 
Rabbits not receiving BHT treatment we r e fed regular 
chow. In the fi rst t wo e xperiments ETOH was added to t he 
chow of non-trea ted rabbits and evapora ted off to de te rmine 
if an afte rtaste of ETOH might affect the appetite of the 
an i mals. No change in appetite was obse r ved ; therefor e, 
ETCH was not added to the chow of non-treated rabbits in 
experiment III and IV. 
Virus 
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HSV-l McKrae strain was obtained from Dr. James Hill, 
Medical College of Georgia in Augusta. Initial samples were 
propagated in primary rabbit kidney cells (PRK cells) and used 
in experiments I and II. Viral samples propagated in 
African g reen monkey cells (CVI-P cells) were used in 
experiments III and IV. 
CVJ-P cells were maintaine d in a growth medium consisting 
of oelbecco Modified Eagle's medium with addition of 10\ fetal 
calf serum (Microbiological Associates), 0.29 9 L-glutamine, 
16 ml of 100X antimycotic antibiotic mixture (Gibco) per 
litre medium and buffered to pH 7.2 with 0.3 g sodium bi-
carbonate. Cells were incubate d at 37°C until the time of 
inoculation . The infected cells were incubated at 37°C for 
four to f i ve days at which time the vi rally infected cells 
began to falloff. Viruses were harvested after incubation 
and centrifuged at 200X g to obtain partially purified virus 
and were stored in vials at a concentration of 10 7 plaque 
f orming units (pfu) per ml at -70°C until used. The number 
o f i nfectious virus ne ce ssary t o p roduce a plaq ue (are a of 
cells destroyed) whe n inoculate d into conf luent mono layers 
of cells in vitro constituted a pfu. Viral stocks were 
diluted into Ca2+ and Mg 2+ free phosphate buffered saline 
(PBS) to obtain the titre desired for infection. 
viral Inoculation 
RAbbits were anesthetized in early experiments by 
intraperitoneal (I P) injections of sodium pentobarbital. 
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In later experiments, rabbits were placed in a glas8 chamber, 
etherized and observed until they became sedate . 
Fifty microlitres of a solution of HSV-l of sufficient 
titre to cause a severe infection of the cornea was 
administered, using a micropipette, to the surface of the 
eye of animals to be infected. The eye was carefully 
massaged for one minute to allow ample spreading of infectious 
virus throughout the superficial tissues of the rabbit eye. 
Eye Readings 
Lesions were usually visable in three to four days 
post-inoculation . Eyes were observed at five days and ten 
days post-inoculation for Experiment I and two day intervals 
after infection for at least ten days for Experiments II, 
III, and IV. 
Lesions were observed and quantitated in the following 
manner: one drop of a fluorescein (Ayerst Labs) solution was 
placed in the eye, the eye was massaged and the lid was then 
pulled back and kept open during observation: the room lights 
we r e shut of f and the eye illuminated with t he output from 
a I S-watt "bl a kli ght" lamp emi tting 97% o f its radiation 
between 300 and 400 nm. These wave l eng ths c aused the 
fluorescein t o fluoresce in the ye llow-green r egion of the 
visible spe ctrum. Corneal e pithe lial l e sions we r e observed 
with the a id of a stereomicroscope (7.0X magnification) 
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and scored on a seve rity scale that ranged from 0 (no 
lesions) to 6 (very heavy lesions). In addition, the extent 
of the corneal surface covered by lesions was measured using 
a grid. The product of the severity value of the daily 
corneal lesion scores and the percent of the cornea covered 
",'as termed the "daily response" (DR). The sum of the daily 
responses for each eye over the entire course of the measure-
ments was termed the "integrated response" (IR). 
Viral Shedding Assays 
In order to ensure that the lesions observed were due 
to HSV-l infection, eye fluid samples were routinely taken by 
adding 0.1 ml of PBS to the corneal surface, closing the lid, 
and gently massaging the eye. After removal of 0.025 ml of 
eye fluid, an assay was performed on CVI-P cells to verify 
that the plaque development rate and plaque morphology was 
s i mi l ar t o that o f HSV-l McKrae s t r a in . 
Experiment I 
Rabbits one through four received no treatment with 
BHT nor were they inoculated with HSV-l (control group). 
~bits five through eight were inoculated with HSV-l McKrae 
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st r ain of a titre of 6 xlO~ pfu (HSV g r oup) . Rabbi ts nine 
t h rough 12 we r e i noculated wi t h HSV-l Mc Krae strain at the 
afore mentioned titre and started r eceivi r.g a di e t of 0.5 \ 
BHT 2 days post-inoculation (HSV-BHT g roup) . Rabbits 13 
through 16 rece ived a diet of 0 . 5% BHT for three days before 
being inoculated with HSV-l McKrae strain o f a titre 
consistent with the above (BHT-HSV group) • 
EXPeriment II 
Rabbits 17 through 20 received no BHT nor were they 
infected with virus. Rabbits 21 through 24 were inoculated 
with 7xlO~ pfu HSV-l HcKrae strain (HSV group). Rabbits 25 
through 28 were inoculated with 7xlO~ pfu HSV-l McKrae 
strain and started receiving a diet of 1\ BHT two days 
post inoculation (HSV-BHT group). Rabbits 29 through 32 
received a diet of 1% BHT for seven days prior to inoculation 
with 7xlO~ pfu HSV-l McKrae strain (BHT-HSV group) • 
Experiment III 
Rabbits 33 and 34 received no BHT in their diet nor 
were they inoculated with virus. Rabbits 35 and 36 were 
inoculated with 1.5xl06 pfu HSV-l (high virus titre) on both 
the right and left eyes. Rabbits 37 and 38 were inoculated 
with 1.5 xlO~ pfu HSV-l (medium virus titre) on both eyes. 
Rabbits 39 and 40 were inoculated with 1.5xl02 pfu HSV-l 
(low virus titre) on both eyes . Rabbits 41 and 42 received 
a diet of 0.5' BHT for a period of five days prior to 
inoculation with 1.5xl06 pfu HSV-l (BHT-high virus titre) 
on both e yes . Rabbits 43, 44 and 45 r ece ived a diet of 
0 . 5\ BHT for a period of five d ays prior t o inocula t ion 
wi th 1 .Sx lO ~ pf u HSV-l (BHT-med ium virus titr e ), rabbit 
43 on both e yes, rabbits 44 and 45 on the ri ght e ye only. 
Rabbi ts 46. 4 7 and 48 recei ve d a die t of 0.5 % SHT for a 
pe r iod of five days pr ior to i noculati on with 1.5xl0 2 pfu 
HSV-l (BHT-low virus titre ) , rabbit 46 being inoculate d 
on both eyes and rabbits 47 and 48 being inoculated on the 
ri ght eye only. 
Experiment IV 
Rabbits 49 through S2 were inoculated with 1.5xl0 6 
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p £u HSV-l (HSV) . Rabbits 53 through 56 received a diet of 
0.001 % BHT for a per i od of fi ve days prior to inoculation 
with 1 . 5xlO ' pfu HSV-l (0.001\ BHT-HSV). Rabbits 57 through 
60 received a diet of 1% BHT for a period of five days prior 
to inoculation wi th 1. 5x l0 6 pfu HSV-1 (1 % BHT-HSV). Rabbits 
61 through 64 received a diet of 5% BHT for a period of five 
days prior to inoculation with 1 . 5x l06 pfu HSV-l (5% BHT-
HSV) . 
RESULTS 
The d ata obtained f r om Expe riments I and II are shown 
in Table I. The data obtained from Experiments III and I V 
are shown in Table II. All data showed the same trend 
whether reported as severity, ?ercent surface area of eye 
covered, daily response or integrated response. The average 
"daily response" value was chosen as the neasure for comparing 
results on the graphs and the "integrated response" value 
was chosen as the measure for comparing results on the 
tables . 
Experiment I 
Rabbits one through four , comprising the control group, 
showed no signs of infection during the course of the 
experiment. The IR values for rabbits five through eight 
(HSV) ranged from 1. 5 to 3.75 with an average of 2.36. Rabbit 
six died after one reading, therefore its IR is not included 
in the range and mean values. The IR values of rabbits nine 
through 12 (HSV-BHT) ranged from 0.31 to 1.9 with an average 
of 0.9 2 . The IR values of rabbits 13 through 16 (BHT-HSV) 
ranged from 0 . 2 to 1.0 wi th an average of 0.55 (Table I). 
The graph in figure 1 indicates the average degree of viral 
i nfe ction per group per reading. The graph indicated BHT 
to be inhibitive to the early development of primary HSV 
lesions since in the first reading, taken five days post-
inoculation, the a verage IR of animals not receiving BHT 
TABLE I 
INTEG RATED RESPONSE EVALUATION 
Sum of I R f o r Number of 
All Ey e s Infected I n f ecte d Eyes 
Experiment I 
Control 0 4 
HSV* 7.09 3 
HSV-SHT 3.66 4 
SHT-SHT 2.2 4 
Experirrent II 
Control 0 4 
HSV 16.49 4 
HSV-SHT 6.67 4 
BHT-HSV* 0.89 3 
*Rabbits 6 and 29 died during course of these experiments 
not included in the data of their respective groups. 
Range of Average 
IR IR'S 
0 0 
1.5 -3 . 75 2.36 ±1.23 
0.31-1.9 0.92 ±0.74 
0.2 -1.0 0.55 ±0.39 
0 0 
0.23-7.1 4.12 ±3.07 
0.4 -3.65 1 .67±1. 47 
0.1 -0.4 0.30±0.17 
and therefore were 
... 
w 
Experiment II I 
Control 
l.5xl0 6 pfu titre 
1.5xlO~ pfu titre 
l . 5xl0 2 pfu titre 
BHT-l.5xl0 6 pfu titre* 
BHT-l.SxlO~ pfu titre 
BHT-l.Sxl0 2 pfu titre 
Experiment IV 
HSV* 
1. 001\ BHT-HSV' 
1\ BHT-HSV 
5% BHT-HSV· 
TAB LE II 
I NTEGRATED RESPONSE EVALUATI ON 
Sum of IR for 
All Eye s Infected 
0 
31. 57 
10.04 
14.42 
2.49 
6.06 
0 
3.4 
1. 06 
1.7 
3.3B 
Number of 
Infected Eyes 
2 
4 
4 
4 
2 
4 
4 
3 
3 
4 
3 
Range of 
IR 
0 
2.53-16.3 
0- 6.55 
0.05- B.B7 
1.04- 1.45 
0- 3.2 
0 
0- 2.45 
0.15- 0.46 
0.2 - 0.9 
0.95- 1.29 
*Rabbits 44, 49, S3 and 63 died during the course of these experiments and 
therefore were not included in the data of their respective groups. 
Average 
IRIS 
0 
7.B9 ' 5.97 
2.51'2.99 
3.6l±4.16 
1.24±1.03 
1.51±1.67 
OtO 
1.13'1.24 
O. 35±1. 71 
0.43±0.32 
1.13±0. B2 
i s 
Fi gure 1. Results of Experiment I: Comparison of severity 
X ' eye surface with lesions of groups receiving 
HS V inoculation, HSV inoculation with BHT 
treatment beginning two days post-inoculation 
and HSV inoculation with BHT treatment beginning 
three days before inoculation. 
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HSV HSV- BHT- HSV HSV- BHT-
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Fig ure 2. Results of Experiment II: Comparison of the 
averag e daily response of groups receiving 
HSV inoculation(.), HSV inoculation with BHT 
treatment beginning two days post-inoculation 
(A) and HSV inoculation with BHT treatment 
beginning three days before inoculation (0). 
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Figure 3. Results of Experiment tIl : Comparison of the 
ave rage daily response of groups a 106 pfu 
viral inoculation ( . ) , a 106 pfu viral 
inoculation with BHT treatment beginning five 
days prior to inoculation ( D ), a 104 pfu viral 
inocul" tion (. ), a 10'* pfu viral inoculation 
with BHT treatment beg inning fi ve days prior 
to inoculation (4), a 10 2 pfu viral inoculation 
( . ) and a 102 pfu vi ral inoculation wi th BHT 
treatment beginning five days prior to 
inoculation ( 0 ) . 
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Figure 4. Results of Experiment IV: Comparison Of average 
daily response of groups receiving a 10 6 pfu 
viral inoculation (46), a 106 pfu viral 
inoculation with a 0.001\ diet of BHT beginning 
five days prior to inoculation ((», a 10 6 pfu 
viral inoculation with a 1\ diet of BHT 
beginning five days prior to inoculation (a), 
a 106 pfu viral inoculation with a 5\ diet of 
BHT beginning five days prior to inoculation 
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TABLE III 
SUf-1MARY TABLE OF RABBITS- EXPERIMENTS I AND II 
Rabbit Infection Maximum 
Number (pfu) BHT IR Severity Inflammation Death 
1 No No 0 0 No Administered 
2 No No 0 0 No Died 6-7-82 
3 No No 0 0 No Administered 
4 No No 0 0 No Administered 
5 6 xl 0 it No 1. 84 5 Yes Administered 
6 6xlO it No 6 No Died 6-7-82 
, Administered 7 6x10 No 3.75 6 Yes 
8 6x10 
, 
No 1. 50 5 Yes Administered 
9 6x10 
, 
0.5 % 0.31 3 Yes Administered 
10 6xlO it 0 . 5 % 0 . 4 3 Yes Administered 
11 6xlO it 0. 5% 1.9 5 Yes Administered 
12 6x10 
, 
0.5 % 1. 05 5 No Administered 
13 6 xlO it 0.5% 1.0 4 No Administered 
14 6xlO it 0.5% 0.2 4 No Admin i s te red 
15 6x10 
, 
0 . 5% 0.75 5 No Administered 
16 6xlO 
, 
0 . 5% 0.25 3 No Administered 
17 No No 0 0 No Administered 
18 No No 0 0 No Administered ... 
'" 
TABLE I II (Continued) 
Rabbit Infection Maximum 
Number (pfu) BHT IR Severi t y 
19 No No 0 0 
20 No No 0 0 
21 7xl0 No 7.1 6 
22 7xIO" No 3. 18 6 
23 7xlO " No 5.98 6 
24 7xlO lt No 0.23 2 
25 7x1O " 1% 0.72 3 
26 7xIO " 1% 0.4 3 
27 7xIO" 1% 1.9 5 
28 7xlO lt 1\ 3.65 6 
29 7xIO " 1% 2 
30 7xIO " 1% 0.39 3 
31 7xlO tt 1\ 0.4 3 
32 7xlO'+ 1% 0 .1 2 
Inflammation 
No 
No 
Yes 
Yes 
Yes 
Yes 
No 
No 
Yes 
Yes 
No 
Yes 
Yes 
No 
Death 
Administe red 
Administered 
Administered 
Administered 
Administered 
Administered 
Administered 
Administered 
Administered 
Administered 
Died 0.0. Ether 
Administered 
Administered 
Administered 
'" <:> 
TABLE IV 
SUMMARY TABLE OF RABBITS - EXPERIMENT III 
Rabbit Infection Maximum 
Nurrber (pfu) BHT IR Severity Inflammation Death 
33 No No 0 0 No Administered 
34 No No 0 0 No Administered 
35 1. 5xlO 6 No 5.19 6 Yes 10-9-82 
1. 6x10 6 No 7.55 6 Yes 
36 1. 5x1 0 ' No 16.3 6 Yes 10-9-82 
1. 5x10 6 No 2.53 4 No 
37 1. 5xlO it No 0.49 5 No 10-9-82 
l.5xlO lo No 6.55 6 No weak, favored 
one eye 
38 L 5xlO It No 0 0 No 10-9-82 
1. 5xlO " No 3.0 6 No weak, facial 
contortions 
39 1. 5xlO 2 No 8.87 6 Ye s 10-9-82 
1. 5x10 ' No 0.05 1 No weak, facial 
contortions 
40 1.5x10' No 5.0 6 No 10-9-82 
1. 5xlO 2 No 0.5 5 No 
41 1. 5xlO 6 0.5\ 0 6 Yes 10-7-82 
1.5x10' 0 5 No respiratory 
problems 
42 1.5x10 ' 0.5\ 1. 04 3 No Administered 
1. 5x10 ' 1. 45 5 No 
N 
.... 
TABLE IV (Con t i nued) 
Rabbit Infection Maximum 
Number ( p fu) BHT IR Severity Inflammation De ath 
43 1. 5xlO 4 0. 5\ 3. 2 5 No 10-7- 82 
heart 
1. 5xlO 4 0.16 2 No puncture-
taking blood 
44 1. 5xlO 4 0.5 \ 0 0 No Administered 
45 1.5xlO 4 0.5 \ 2.7 5 No Administered 
46 1.5xlO2 0.5 \ 0 0 No Administered 
1. Sx10 2 0 0 No 
47 1. 5xlO 2 0.5\ 0 0 No Administered 
48 1.5xlO2 0.5\ 0 0 No Administered 
TABLE V 
SUMMARY TA8LE OF RABBITS-EXPERIMENT IV· 
Rabbit I nfection Maximum 
Nuni>er (pfu) BHT IR Severity Death 
49 1. 5x10 . No 0 Died 2-3-83 
50 1. 5x10 · No 0 u Administered 
51 1. 5x10 . No 2.45 6 Administered 
52 1. 5x10 · No 0.95 4 Administered 
53 1.5x10· 0.001\ 2.76 6 Died 2-14-83 
54 L5xlO 6 0.001\ 0.45 3 Administered 
55 1.5x10 · 0.001\ 0 . 45 4 Administered 
56 1.5x10· 0.001\ ~ . 41; 3 Admini s te red 
57 1.5x10· 1\ 0.90 (; A-iministered 
58 1. 5x10 . 1\ 0.3 3 Admird stered 
59 1.5x10· 1\ 0.20 2 Administered 
60 1. 5x10. 1\ 0.30 2 Administered 
61 1.5x10· 5% 0.95 6 2-21-83 Was not eating 
62 1.5x10· 5% 1.14 6 2-14-83 Was not eating 
63 1.5x10· 5% 0 0 2-10-83 Was not dating 
64 1.5xlO · 5% 1.29 4 2··22-83 Wa~ not eating 
·Inflammation was not observed. 
'" w
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was g reate r by a fac tor of s ix o r mo r e than the average IRIs 
of animal s r e ceiving a BHT diet. The s econd r ead in g taken 
ten days post-inoc ulatio n i ndicate s the course of infec tion 
to be decreasing with the exception o f the g roup which 
began a BUT d iet two days post-inocu lation (HSV-BHT). 
Experl~nt II 
Rabbits 17 through 20 showed no signs of i nfection 
during the course of the experiment (control group). The IR 
values of r&?bits 21 through 24 ranged from 0.23 to 7.1 with 
an a ve rage of 4.12 (HSV group). The IR values of rabbits 2S 
through 28 ran~ed from 0.4 to 3.65 with an average of 1.67 
(HSV-BHT group). The IR v alues of rabbits 29 through 32 
ranged from 0.1 to ~. 3 with an average of 0 .3 (BHT- HSV 
group). Rabbit 29 died from an overdose of ether after two 
readings. thus i ts I F. va l ue was n ot include d in t he dete r-
mination of the r~nge and mean values o f the BHT-HSV group 
\ T~i~ I). The graph in figure 2 shows the course of 
infection over eight days for the three groups that were 
inoculated with the virus using average daily response values 
per group as the criteria. The daily response values peaked 
at day six post-inoculation for the HSV group and the HSV-BHT 
group, however, the infection for the group not receiving BHT 
was three fold hi gher at day six . The average daily response 
value of the g roup receiving BHT seven days previous to 
inoculation showed early inhibition of virus with some 
increased infection by days six to eight post-inoculation. 
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The daily re s ponse of the BHT- HSV g roup during t he cours e of 
the experiment i ndicated inhi bition of p r ima ry i n fection by 
dietary BHT. 
Experiment I I I 
Rabbits 3 3 and 34 showed no sig n o f in fec tion through-
out the course o f the expe rime n c . The IR value s of the four 
eyes inoculate d with a high v i rus titre (rabbits 35 and 36) 
ranged from 2 . 53 to 16.3 with an ave rage of 7.89. The IR 
values of the four eyes inoculated with a medium virus titre 
(rabbits 37 and 38) ranged from 0 to 6.55 with an average of 
2.51. The IR values of the four eyes inoculated with a low 
v irus titre (rabbits 39 and 40) ranged from 0.05 to 8.87 with 
an ave rage o f 3. 6 1 . The IR v alues of the BHT-high virus titre 
g roup (rabbits 41 and 42) were obtained from two eyes. 
Rabbit 41 died of re spiratory problems during the course of 
the experiment and was not considered in the data. The IR 
v alues of the two inoculated eyes of rabbit 42 had a range 
o f 1.04 to 1.45 with an average of 1.24 . The IR values of 
the f our inoculated eyes of rabbits 43, 44 and 45 (BHT-
medium virus titre group) ranged from 0 to 3 . 2 with an 
average of 1.51. The four inoculated eyes of rabbits 46 , 47 
and 48 (BHT-1ow v irus titre group) showed no signs of 
in fe cti on throughout the course of the experiment (Table II) . 
All animals inoculated with HSV-I McKrae strain not fed a 
0.5 \ diet of BHT died within 14 days post-inoculation. The 
g raph in fig ure 3 depicts the average daily response 
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indicat i ng t he c o u rse of the in f ection per g roup. Al l 
groups inoc ul ated wi th H5V-l Mc Krae strain and not fed 
dietary BHT s howed h ig her avera ge daily re s ponse value s than 
BNT f e d g roups of the c orres pondi ng viral titres. 
Expe riment IV 
The I R values f o r rabbits 49 through 52 ranged from 0 
to 2.45 wi th an a verage of 1.13. The IR values f or rabbits 
53 thr ough 56 (0.001 \ BHT-H5V) ran ged from 0.15 to 0.46 with 
an average o f 0 . 43. The IR values of rabbits 61 through 64 (5\ 
BHT-HSV) r anged f rom 0.95 to 1.29 with an average of 1.13 
(Table II) . Rabbits 49. 53 and 63 died during the course of 
the experiment; therefore,the data were not included in the 
respective g roup data. The animals in the 5% BHT-HSV group 
did not eat at normal levels, lost weight and died . The 
graph in figure 4 illustrates the average daily response 
per g roup. Although overall v i ral infectivity appears lower, 
the average daily response peak for the HSV group was at 
l east threef o ld greater than the peak for any group receiving 
BHT. 
Vi ral Shedding Assays 
The eye fluid samples taken for infection of CVI-P cells 
in e very case showed a plaque development rate and plaque 
morphology consistent to that for HSV-I McKrae strain. Ob-
served also was an approximate quantitative agreement between 
the extent and severity of the eye lesions at the time of 
sampling and the amount o f virus recovered. 
Tab l e s Ill. IV and V summarize the history of each 
rabbit t ,hroug ho ut the course of its r e s pective experime nt. 
Inf lammation as evide nced by incre as e d v~scul arization of 
the super ficial tissue s of the conjunctiva was observed 
in only some of the animals and gene rally appeared in 
animals infected with higher titres of vi rus during period 
of g reatest infectivity. 
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DISCUSSION 
Vira utilization of t he host cell 's machinery f or the 
s yn thesis of new vi rions limits antivi ral chemothe rapy due to 
the possible ill-effects that may be induced in cells. Most 
advances in antiviral chemo therapy involve interference with 
viral nucleic acid metabolism by compounds that are structural 
analogs to normal precursors of nucleic acid biosynthesis. 
These analogs show limited discrimination between host cell 
and viral functions and may elicit cytotoxicity, teratogenesis, 
mutagenesis and carcinogenesis (Park, et a1., 1978). Due to 
the toxicity and other effects mentioned, new perspectives 
must be investigated for viral inactivation. In the case of 
membrane enveloped viruses, studies may involve antiviral 
agents that interfere with membrane-associated functions. 
The mechanism by which the antiviral effects of BHT are 
achieved in vivo remains unknown at the present. It has been 
suggested that its activity is membrane associated. Being 
extremely hydrophobic, BHT localizes almost entirely in the 
hydrocarbon phase of membranes and acts as a membrane 
perturber modifying the orderly stacking of membrane's alkyl 
chains in the lipid bilayer region (Deluca, et al . , 1980). 
This perturbanoe may disrupt the continuity of the viral 
membrane, preventing viral adsorption to the host cell (Keith, 
et al., 1982), or it may alter the protein components of the 
viral envelope (Wanda, et al . , 1976). The small radius of 
curvature of the viral membrane, in comparison to the cell 
plasma membrane, may be responsible for the greater 
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s e nsitivi ty of the vi r al membrane e nvelope (Snipes and 
Keith, 1978). The observance of the perturbance of the viral 
membran e by BHT without disrup tion o t the host cell membrane 
function has been r eported (Deluca, et al., 1980) . Most 
antiviral compounds act either on RNA or DNA viruses. BHT, 
however, has been shown to be an e ffective antiviral a ge nt 
against both RNA (Brugh, 1977) and DNA (Snipes, 1975) 
enveloped viruses, thereby eluding to the possibilities for 
the development of BHT as a broad spectrum antiviral 
chemotherapeutic agent. Past studies show BHT to be 
antivirally effective in vitro. 
The results of Experiments I and II of this study suggest 
that orally administered BRT can be an effective inhibitor 
of primary HSV infection in vivo and that the timing of BHT 
administration, in relation to viral exposure, is important. 
A comparison of the daily response of the three groups 
employed i n Experiment I at day five post-inoculation implies 
that BHT is an effective inhibitor of HSV-1 primary infections 
at least in the early stages. However, only two readings 
were taken during the course of the first experiment. The 
second reading taken ten days post-inoculation indicated a 
subsidence of the infection in the animals inoculated with 
HSV not receiving BRT and animals receiving BHT prior to 
HSV inoculation . The group that began receiving BHT two 
days post-inoculation showed a higher daily response than 
at day five post-inoculation. Though it appeared that 
animals treated with BHT had a lower level of infection 
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and that administration of BHT i s most effective prior to 
viral exposure, it is apparent from figure 1 that more 
readings throughout the course of the experiments were needed 
in order to monitor the course of infection. In Experiment 
II , readings were taken at two day intervals starting two 
days post-inoculation. The DR values of all groups were 
similar in the early stages; however, from day four, the 
level of infection increased at a faster rate for animals 
i nfected with HSV not being maintained on a 1% diet of BHT. 
Figure 2 shows the peak of the level of infection at six 
days post-inoculation which is consistent with the results 
obtained by Kwon and co-workers (1979). On day six at the 
peak in the level of infection, the non-BHT group showed 
DR values higher by fourteen-fold than the group that 
started receiving BHT treatment prior to infection. By 
day eight the level of infection appeared to decrease in all 
groups except the group inoculated with HSV after treatment 
of BHT had begun. The average DR values, however, of this 
group were still lower at day eight by a fac tor of two than 
the group infected with HSV that did not receive BHT. The 
results of Experiment II appeared consistent with those of 
Experiment I which implies that oral admdnistration of BHT 
may inhibit the primary infection of HSV in rabbit eyes and 
that administration prior to infection may be most effective. 
Experiment III, in which the degree of viral exposure 
was varied, had readings taken at two day intervals through 
day ten post-inoculation. Consistent with Experiment II, the 
e arly course of i n fection was simi lar fo r g rou p s r ece i v ing 
BHT and g roups not r e cei v i n g SliT. Al da y fo ur post- i noc-
ulation the BHT g r oup r e c eivin g an i nocula t i o n of 10 6 pE u 
peake d an d thereafte r dec r e a s ed i n i t s l e ve l ot tn ce t i o n. 
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Th e non- 8 HT g roup i nocul a t e d with 10 6 p f u peaked a t day si x . 
The OR values for t he s e t wo g roups at t h eir r e s pec t i ve 
peaks di f fere d by a f actor of th ree wi th the gro up not 
receiving 8HT show i ng the g r e ater deg r ee o f infection through-
o u t the course of t he e xpe riment. The final DR values 
showed t ho s of he n o n - BIIT g r oup t o b e great er 
by two- f old at t he fi nal readin g on day ten . The two 
groups in fecte d wi th a titre of lO ~ pfu showed the DR value 
f or the non-BHT group to be greater by a factor of three on 
d ay e ight whe n the level of infection peaked for the non-BHT 
g roup. The g roup receiving BHT showed its highest degree of 
i nfection on day t e n post-inoculation. The two groups 
inoculated with the lowest viral titre of 10 2 pfu showed 
that, in some cases, orally administered BUT may prevent 
p rimary i nfection of HSV in rabbit eyes. The level of 
i nfection of the g roup not receiving BHT appeared to be 
continually increasing at day ten. The group maintained on 
a 0 .5 % diet of BHT and infected with 10 2 pfu showed no 
s ign o f infection throughout the course of the experiment. 
As the viral exposure decreased, the effectiveness of the 
BHT treatment in inhibitin g t he p r i ma r y i n fec tio n appeared to 
increase. These results indicate that a 0 . 5 % diet of BHT 
inhibits and in some cases may preve nt primary HSV 
infectio ns in rabbi t e yes depending on the degree of viral 
exposure. 
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All rabbits in Experiment III that d id not r eceive a 
d i e t of 0.5 \ BHT died within 14 days post-inoculation. Many 
of these rabbits e xhibited signs of increasing weakness and 
fac i al paralysi s until death occurred. Stevens and Cook 
(1971) r ported that HSV infection elicited paralysis in the 
hind l egs of mice. Although no pathological studies were 
performed in this r e search, it has been reported that severe 
HSV i nfections of the cornea may cause viremia and 
e ncephalitis (Narang , 1982; Gangarosa, et al., 1979) and 
may have been the cause of death in this experiment. 
Six of the ten rabbits inoculated in both eyes showed 
an interesting phenomenon in that the IR value of one eye 
appeared to be significantly lower than the IR value of 
the other eye. This becomes more interesting when it is 
considered that two of the ten rabbits were fed BHT and no 
signs of infection were observed for either of their eyes. 
It may be possible that the course of infection of one eye 
advanced more rapidly triggering the immune system to elicit 
a higher antibody titre limiting the observed level of 
infection in the second eye. No studies were performed to 
verify this hypothesis. However, it may merit fur ther 
investigation in the future in regard to an attempt to 
correlate antibody titre with the time of viral e xpo.ure. 
In Experiment IV, in which the effectivene~8 of varying 
dosages of BHT was compared on animals i noculated with a 
viral titre of 10 6 pfu, the overall level of infectivity 
appeared t o decrease. The peak of the level of infection 
was observed at 6-8 days post-inoculat : on. The DR value 
of the g roup not r e ceiving BHT was greater by fivefo Jd 
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than a ny of t he grou 5 r ec ivin g BHT. Th e r an ge o f 0 .001% to 
l ' diets o f BHT appeared to be the most effective dose 
range. The group fed a diet of 5% BHT did not eat at normal 
levels and therefore probably did not ingest the 5\ level 
of aHT. The actual level of BHT consumed, if any, is 
unknown. Although the graph in figure IV shows this group 
to have the lowest leve l of infectivity, all of the animals 
of this group eventually stopped eating and died. 
In summary , these experiments answered a sequence of 
questions pertaining to the effectiveness of BHT as an 
antiviral agent. First, BHT appears to inhibit primary HSV 
infections in rabbit eyes and BHT administration prior to 
inoculation is most effective; second, the effectiveness 
of BHT increases as viral exposure decreases . Finally, the 
most e ffective dose range of BHT for treatment of primary 
herpes keratitis infection in rabbits was found to be 0.001% 
to 1%. 
Along with HSV-1, BHT may be found to be effective 
in treatment of HSV-II which has been reported to represent 
the major venerea l disease in the United States and has been 
strongly correlated to cervical cancer (Rapp, 1978). Since 
the virus persists in latency in the nervous system, the 
disease is cumulative in the population; and no treatment 
thus far has been proven t o be complete l y effective as 
a cure. I n gested BHT, being stored in the lipid layer o f 
the myelin sheath of axons, may e licit a disruptive effect 
on HSV in latency. Further inve stigations could involve 
the effect of BHT on late nt HSV, HSV infections in other 
areas of the body and on other enveloped viruses in vivo. 
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